Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Urbanowicz

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Pathogens (Basel, Switzerland)|September 28, 2021
The Distribution of <i>Puumala orthohantavirus</i> Genome Variants Correlates with the Regional Landscapes in the Trans-Kama Area of the Republic of TatarstanYuriy N Davidyuk, Emmanuel Kabwe, Anton F Shamsutdinov, et al.
NPJ Vaccines|August 18, 2020
Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activityHelena Müller, Sarah Katharina Fehling, Jens Dorna, et al.
Antiviral Research|October 28, 2017
A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivoIsabelle Desombere, Ahmed Atef Mesalam, Richard A Urbanowicz, et al.
The Journal of General Virology|January 13, 2026
Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independentJessica L Mimms, Ariadne Sinnis-Bourozikas, Nathaniel R Felbinger, et al.
Journal of Virology|January 18, 2019
Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect CellsRichard A Urbanowicz, Ruixue Wang, John E Schiel, et al.
Plos Neglected Tropical Diseases|April 13, 2021
Correction: A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype CFederico Napolitano, Rossella Merone, Adele Abbate, et al.
Journal of Virology|September 4, 2020
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-NeutralizationBrian G Pierce, Zhen-Yong Keck, Ruixue Wang, et al.
Journal of Hepatology|July 10, 2024
Recombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 aloneJuthika Kundu, Hoa T Le, Michael Logan, et al.
Plos Neglected Tropical Diseases|July 16, 2020
A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype CFederico Napolitano, Rossella Merone, Adele Abbate, et al.
Science Translational Medicine|August 11, 2021
Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infectionRichard A Urbanowicz, Theocharis Tsoleridis, Hannah J Jackson, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Pathogens (Basel, Switzerland)|September 28, 2021
The Distribution of <i>Puumala orthohantavirus</i> Genome Variants Correlates with the Regional Landscapes in the Trans-Kama Area of the Republic of TatarstanYuriy N Davidyuk, Emmanuel Kabwe, Anton F Shamsutdinov, et al.
NPJ Vaccines|August 18, 2020
Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activityHelena Müller, Sarah Katharina Fehling, Jens Dorna, et al.
Antiviral Research|October 28, 2017
A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivoIsabelle Desombere, Ahmed Atef Mesalam, Richard A Urbanowicz, et al.
The Journal of General Virology|January 13, 2026
Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independentJessica L Mimms, Ariadne Sinnis-Bourozikas, Nathaniel R Felbinger, et al.
Journal of Virology|January 18, 2019
Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect CellsRichard A Urbanowicz, Ruixue Wang, John E Schiel, et al.
Plos Neglected Tropical Diseases|April 13, 2021
Correction: A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype CFederico Napolitano, Rossella Merone, Adele Abbate, et al.
Journal of Virology|September 4, 2020
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-NeutralizationBrian G Pierce, Zhen-Yong Keck, Ruixue Wang, et al.
Journal of Hepatology|July 10, 2024
Recombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 aloneJuthika Kundu, Hoa T Le, Michael Logan, et al.
Plos Neglected Tropical Diseases|July 16, 2020
A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype CFederico Napolitano, Rossella Merone, Adele Abbate, et al.
Science Translational Medicine|August 11, 2021
Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infectionRichard A Urbanowicz, Theocharis Tsoleridis, Hannah J Jackson, et al.
Pageof 6